NHC Stock Analysis: Buy, Sell, or Hold?
NHC - National Healthcare Corp.
$226.03
-2.94 (-1.28%)
▼
5d:
+0.15%
30d:
+6.26%
90d:
+30.43%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 14, 2026
10d
Get Alerted When NHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NHC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NHC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NHC is currently trading at $226.03, which is considered extended relative to its 30-day fair value range of $208.99 to $225.71.
Technical Outlook: Technically, NHC is in a strong uptrend. The price is approaching resistance at $232.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $6.15. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NHC is in a strong uptrend. The price is approaching resistance at $232.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (20th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. However, the stock is trading significantly above the average Wall Street target of $6.15. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$208.99 -
$225.71
Company Quality Score
57/100
(HOLD)
Options IV Signal
20th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
52.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 20th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 97.3% above Wall St target ($6.15)
Trading Range Analysis
30-Day Trading Range
$208.99 -
$225.71
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$12.22
(5.4%)
Support & Resistance Levels
Support Level
$216.39
Resistance Level
$232.67
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.89
Wall Street Target
$6.15
(-97.3%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
9.7%
Profit Margin
8.1%
Share & Embed Analysis
Last updated: August 02, 2026 10:59 PM ET
Data refreshes hourly during market hours. Next update: 11:59 PM
Data refreshes hourly during market hours. Next update: 11:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
